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Summary 
 
We hypothesized that increasing 
concentrations of progesterone after artificial 
insemination (AI) would increase fertility. Our 
objective was to assess changes in ovarian 
structures, incidence of ovulation, and change 
in serum progesterone in response to GnRH, 
human chorionic gonadotropin (hCG), or 
exogenous progesterone (controlled internal 
drug release; CIDR insert) treatment, 
beginning 4 to 9 days after AI (d 0) and again 
7 days later (Exp. 1). Blood was collected 
from 753 cows in 3 herds on days 0 and 7. 
Ovaries of 162 cows in 1 herd were scanned  
and mapped to confirm the presence a corpus 
luteum (CL), and cows were assigned 
randomly to serve as control (n = 41) or to 
receive a CIDR insert for 7 days (n = 41), 100 
μg of GnRH (n = 40), or 3,300 IU of hCG (n = 
40).  More cows were induced to ovulate in 
response to GnRH (60%) and hCG (78%), 
compared with control (2.4%). Compared with 
control, cows treated with GnRH or hCG had 
more induced CL (d 7) and more total CL (d 
7), but serum progesterone was increased only 
in response to hCG. Volume of the original 
luteal structures was increased by hCG, but 
tended to be reduced by CIDR and GnRH, 
compared with luteal volume in control. Total 
CL volume was increased by hCG, but 
reduced by CIDR, compared with CL volume 
of control. In Exp. 2, cows in 5 herds were 
used to assess conception rates in response to 
the same treatments described in Exp. 1: 
control (n = 708), CIDR (n = 711), GnRH (n = 
719), and hCG (n = 714). Tendencies for 
interactions of treatment × herd and treatment 
× lactation group were detected, but no 3-way 
interactions were found. Treatment with hCG 
increased conception rates in second-lactation 
cows. The CIDR tended to increase, and hCG 
increased, conception rates in 2 herds, 
whereas the CIDR decreased conception rates 
in 1 herd. We concluded that GnRH and hCG 
effectively induced ovulation, and increased 
number of CL, but only hCG increased serum 
progesterone. Further, treatment with the 
CIDR or hCG increased conception rates, but 
only in some herds. 
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Introduction 
 
Conception failure is coincident with less-
than-normal concentrations of progesterone as 
early as day 6 after insemination. In general, 
blood concentrations of progesterone rise 
earlier and achieve greater concentrations in 
pregnant, than in nonpregnant, cows. Embryo 
development is associated with concentrations 
of progesterone and the ability of the 
conceptus to secrete the antiluteolytic 
hormone, interferon-tau. Exogenous pro-
gesterone has been shown to stimulate embryo 
development. A number of treatments could 
be employed to increase peripheral 
concentrations of progesterone after AI, 
including those that increase endogenous 
function of the existing corpus luteum (CL), 
induce accessory CL, or supplement progestin 
or progesterone directly. 
 
Human chorionic gonadotropin (hCG) has 
activity similar to LH, is able to bind to tissue 
LH receptors, and mimics effects of LH by 
causing small luteal cells to increase 
progesterone synthesis. Administration of 
hCG increases the incidence of ovulation and 
accessory CL formation. In addition, luteal 
phase treatment with hCG after AI increased 
conception rates in some studies. 
 
Inducing accessory CL with GnRH or its 
agonists is well documented and forms the 
basis for the first GnRH injection of the 
Ovsynch protocol. Other research has 
demonstrated that incidence of ovulation was 
greatest when GnRH was injected between 
days 5 and 12 of the estrous cycle. 
 
Studies that administered exogenous 
progestins during the luteal phase after AI by 
applying a progesterone-releasing intravaginal 
device (PRID) for 7 days produced 
inconsistent effects on conception rates. No 
increase in conception rates was detected 
when intravaginal controlled internal drug 
release (CIDR) inserts were applied mid-cycle 
or later. In contrast, when treatments were 
initiated before midcycle, conception rates 
were improved for cows treated with CIDR 
inserts for 6 or 12 days, beginning 4 to 9 days 
after AI, compared with control (Macmillan 
and Peterson, 1993). The treatment that most 
consistently improved conception rates in that 
study was a 6- or 12-d CIDR insert beginning 
on 6 to 8 days after AI. 
 
We hypothesized that increasing or 
supplementing endogenous concentrations of 
progesterone in lactating dairy cattle early 
after AI may spare embryonic loss and 
improve overall conception rates. Our overall 
objective was to investigate the effect of 
supplemental blood progesterone and 
exogenous GnRH and hCG on follicular 
development, incidence of ovulation, serum 
progesterone, and conception rate. 
 
Procedures 
 
Lactating Holstein cows were blocked by 
days in milk and lactation number (1 vs. 2+) 
and assigned randomly to 1 of 4 treatments: 1) 
insert a new CIDR (Eazi-Breed CIDR insert 
containing 1.38 g of progesterone; Pfizer 
Animal Health, New York, NY) for 7 days, 
beginning between 4 and 9 days after AI; 2) 
3,300 IU of hCG, i.m. (Chorulon; Intervet, 
Millsboro, NJ) once between 4 and 9 days 
after AI; 3) 100 µg of GnRH, i.m. (Fertagyl; 
Intervet) once between days 4 and 9 after AI; 
and 4) untreated control. Body condition 
scores (1 = thin and 5 = fat) were assigned at 
treatment. 
 
 Experiment 1.   The purpose of Exp. 1 
was to assess ovarian responses to GnRH, 
hCG, and exogenous progesterone (CIDR 
insert). Ovaries of 162 lactating Holstein cows 
housed at the Kansas State University Dairy 
Teaching and Research Center were scanned 
by using transrectal ultrasonography. Ovarian 
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structures were mapped and sized on the day 
of treatment and 7 days later to determine the 
incidence of ovulation in response to 
treatment. 
 
Blood was collected at the initiation of 
treatments and 7 days later to measure 
treatment effects on serum concentrations of 
progesterone.  Cows located in the Kansas 
State University dairy, and at 2 commercial 
dairy farms in which Exp. 2 was conducted, 
had blood samples collected as described 
relative to treatments. Blood serum 
concentrations of progesterone were 
determined by radioimmunoassay. 
 
 Experiment 2.  The purpose of Exp. 2 was 
to assess effects of treatments on conception. 
A total of 2,852 lactating Holstein cows were 
treated in the Kansas State University herd 
and at 4 commercial dairy locations (3 herds 
in Kansas and 1 herd in Wisconsin. Pregnancy 
was diagnosed by using either transrectal 
ultrasonography or transrectal palpation, and 
pregnancy was reconfirmed in all pregnant 
cows at 14 to 30 days. Conception rates were 
calculated based on the number of pregnant 
cows at each diagnosis divided by the number 
of cows previously inseminated and treated. 
 
Results and Discussion 
 
Retention of CIDR inserts during 7 days 
was 94.5% of 752 cows treated with CIDR 
inserts.  Only 711 cows in which the CIDR 
was retained according to protocol were 
included in analyses. Cows were treated after 
AI, which included those occurring at 1 fixed 
time (timed AI; TAI), after visual detection of 
estrus, or in response to rubbed tail chalk, 
activity tags, and other miscellaneous signs of 
estrus. All cows were inseminated postpartum 
(first AI after calving) after 
presynchronization of estrous cycles 
(Presynch) and synchronization of ovulation 
(Ovsynch).  In cows diagnosed not pregnant, 
ovulation was resynchronized by using 
Ovsynch. More than 80% of inseminations 
that preceded treatments in both experiments 
were by TAI. 
 
 Experiment 1.  Ovarian characteristics of 
162 treated cows are summarized in Table 1.  
Because a large percentage of the cows 
eligible for treatment at 4 to 9 days after AI 
were previously TAI, only cows that had a CL 
consistent in size for that stage of the estrous 
cycle or pregnancy at the first ultrasound 
exam were included in Exp. 1.  Mean 
diameter, just before treatment, of follicles 
that eventually ovulated in response to either 
GnRH or hCG did not differ (13.8 ± 0.5 vs. 
12.7 ± 0.4 mm).  More (P<0.01) cows treated 
with GnRH and hCG ovulated at least 1 
follicle than did control cows.  When only 
cows having at least 1 follicle ≥ 10 mm in 
diameter at treatment were considered, 
percentage of follicles that ovulated increased 
to 64.1% and 81.3% for GnRH and hCG 
cows, respectively (Table 1). Number of 
induced CL per cow and total CL per cow 7 
days after treatment were greater (P<0.01) in 
cows treated with GnRH and hCG than in 
control cows (Table 1). 
 
As expected, original CL increased in 
diameter and volume during 7 days after 
treatment in all cows, but increases in 
diameter (P = 0.07) and volume (P<0.05) 
tended to be, or were, greater for cows treated 
with hCG than for control cows.  In contrast, 
change in volume of original CL after 7 days 
in cows from CIDR and GnRH treatments 
tended (P = 0.07) to be less than in control 
cows. As a consequence, total luteal volume 7 
days after treatment was less (P<0.01) in 
CIDR treatment, but greater in hCG treatment, 
compared with control (Table 1). 
 
Concentrations of progesterone in serum at 
the time of treatment and 7 days later were 
determined in 753 cows in 3 herds. As 
 28
hCG increased (P < 0.05) conception rates in 
second-lactation cows (Table 4). Overall, a 
priori contrasts indicated that the CIDR tended 
(P = 0.075) to increase and hCG increased 
(P<0.05) conception rates, compared with 
control (Table 3). 
expected, average concentration of progester-
one in blood serum increased (P<0.001) from 
day of treatment (4 to 9 days after AI; 3.2 ± 
0.1 ng/mL) until 7 days later.  Increase in 
serum progesterone from treatment to 7 days 
later, however, was greater (P<0.001) in cows 
treated with hCG than in control cows (Figure 
1). 
 
Conception rates were influenced by herd; 
rates were greater (P<0.05) in 2 herds (herd 1 
= 38.9% and herd 3 = 36.6%) in which 
pregnancy was diagnosed earlier after AI, 
compared with the 3 herds in which pregnancy 
was determined later by palpation (herd 2 = 
30.9%, herd 4 = 29.3%, and herd 5 = 23.9%). 
Month of treatment (P<0.05), days in milk 
(P<0.001), body condition score (P<0.001), 
and number of days after AI when treatment 
was initiated (P<0.05) influenced conception 
rates, whereas most recent test-day milk yield 
had no effect.  Average day effects across 
herds indicated that conception rates increased 
when treatment occurred after day 6 (day 4 = 
26.6%, day 5 = 27.6%, day 6 = 26.2%, day 7 
= 34.1%, day 8 = 32.5%, and day 9 = 44.5%; 
no treatment × day interaction). Conception 
rates in response to treatments, based on day 
after AI when treatment was initiated, are 
illustrated in Figure 1. 
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Figure 1. Change in Concentrations of 
Progesterone in Serum Between Day of 
Treatment and 7 Days Later for Cows in 
Exp. 1.  *Different (P<0.001) from control. 
 
 
 Experiment 2.  Conception rates of 2,852 
cows in 5 herds described in Tables 2 and 3 
were assessed by ultrasonography in 2 herds 
(herds 1 and 3) and by palpation per rectum of 
uterine contents in 3 herds (herds 2, 4, and 5). 
Tendencies were detected for interactions of 
treatment × herd (P = 0.11) and treatment × 
lactation group (P = 0.07), but no 3-way 
interactions were detected. Treatment with the 
CIDR tended to (P<0.10) increase, or 
increased (P< 0.01), conception rates in herds 
1 and 3, whereas the CIDR decreased 
(P<0.05) conception rate in herd 4, compared 
with rates in the control herd (Table 3).  
Treatment with hCG increased (P<0.05) 
conception rates in herd 3. Treatment with 
 
 
Treatment of lactating dairy cows once 
with GnRH and hCG between 4 and 9 days 
after AI effectively induced ovulation, and 
increased number of CL (not total CL volume 
after GnRH), but only increased serum P4 in 
hCG-treated cows. Further, treatment with the 
CIDR tended to increase, and treatment with 
hCG increased, conception rates, but only in 
some herds.  Treatment of second-lactation 
cows with hCG increased conception rates. 
Further work is warranted to determine how 
and when vaginally applied progesterone via 
the CIDR may influence conception rates. 
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Table 1.  Ovarian Characteristics Before (day 0) and After (day 7) Post-insemination 
Treatments of Progesterone (CIDR insert), GnRH, and hCG in Lactating Dairy Cows 
(Exp. 1) 
 Treatment1
Trait Control CIDR GnRH hCG 
Cows, no. 41 41 40 40 
 Mean ± SE (n) or % (n) 
Induced ovulation 
   % of cows 
   % of follicles 
 
2.4 (41) 
2.9 (34) 
4.9 (41) 
5.6 (36) 
60.0** (40) 
64.1** (25) 
77.5** (40) 
81.3** (37) 
Induced CL, (day 7)  0.1 ± 0.1 (41) 0.1 ± 0.1 (41) 0.7 ± 0.1** (40) 1.1 ± 0.1** (40) 
Total CL (day 7)  1.6 ± 0.1 (41) 1.3 ± 0.1 (41) 2.0 ± 0.1* (40) 2.4 ± 0.1** (40) 
Change in diameter of 
original CL2, mm 3.1 ± 0.7 (55) 2.4 ± 0.7 (50) 1.6 ± 0.7 (50) 4.7 ± 0.7† (52) 
Change in volume of 
original CL2, mm3 3,131 ± 619 (55) 1,350 ± 662† (50) 1,446 ± 652† (50) 4,766 ± 640* (52) 
Total luteal volume 
(day 7), mm3 12,298 ± 1106 (41) 8,008 ± 1101** (41) 12,373 ± 1117 (41) 18,410 ± 1108** (41) 
†Different (P = 0.07) from control. 
*Different (P<0.05) from control. 
**Different (P<0.01) from control. 
1Cows were treated once with GnRH, hCG, or a CIDR insert, beginning 4 to 9 days after AI.  The 
CIDR insert was removed 7 days later. 
2 Trait assessed on day 7 minus that on day 0. 
 
 
Table 2. Conception Rates by Herd in Response to Post-insemination Treatments of 
Progesterone (CIDR insert), GnRH, and hCG in Lactating Dairy Cows (Exp. 2) 
 Treatment1, % (n) 
Herd Control CIDR GnRH hCG 
1 
2 
3 
4 
5 
Total2
31.7 (41) 
26.0 (158) 
26.9 (143) 
33.8 (206) 
23.8 (160) 
28.3 (708) 
50.1† (40) 
30.8 (158) 
40.3** (162) 
23.4* (204) 
22.3 (147) 
32.7 (711) 
32.6 (40) 
28.6 (159) 
31.3 (153) 
29.8 (209) 
20.2 (158) 
28.1 (719) 
38.7 (38) 
34.0 (158) 
37.8* (153) 
33.7 (209) 
25.6 (156) 
33.6 (714) 
†Different (P<0.10) from control within herd, based on unadjusted Chi-square. 
*Different (P<0.05) from control within herd, based on unadjusted Chi-square. 
**Different (P<0.01) from control within herd, based on unadjusted Chi-square. 
1Cows were treated with once GnRH, hCG, or a CIDR insert, beginning 4 to 9 days after 
AI.  The CIDR insert was removed 7 days later. 
2A tendency (P = 0.11) for a treatment by herd interaction. Adjusted a priori contrasts: 
CIDR vs. control (P = 0.075) and hCG vs. control (P<0.05). 
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Table 3. Conception Rates by Lactation Group in Response to Post-insemination 
Treatments of Progesterone (CIDR insert), GnRH, and hCG in Lactating Dairy Cows 
(Exp. 2) 
 Treatment1, % (n) 
Lactation Number Control CIDR GnRH hCG 
First 
Second 
Third 
32.8 (246) 
26.0 (204) 
26.5 (258) 
34.9 (252) 
34.0 (203) 
31.2 (256) 
36.0 (249) 
27.1 (208) 
22.3 (262) 
33.2 (250) 
39.6**(208) 
29.1 (256) 
**Different (P<0.01) from control within lactation number, based on unadjusted Chi-
square. 
1Cows were treated once with GnRH, hCG, or a CIDR insert, beginning 4 to 9 days after 
AI.  The CIDR insert was removed 7 days later. 
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